Dr. Edward Emanuel Manche, MD

Dr. Manche practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Manche's NPI, 1992863443, was assigned on December 5, 2006. Dr. Manche graduated from Albert Einstein College of Medicine in 1990. Dr. Manche's California license number on file is G17270.

Dr. Manche's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Manche's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Manche to 1 more hospital, named with a free account. Dr. Manche's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manche practices, 2 sites in all. Vendor and product names are available with a free account.

Cornea and external diseases specialist is Dr. Manche's primary specialty in the NPI Registry, under taxonomy code 207WX0120X. Dr. Manche is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Manche's licenses on file in 3 states: California, New York and New Jersey.

Dmand AI lists dry eye and hereditary corneal conditions among the conditions Dr. Manche treats.

CMS data shows 127 Medicare services from Dr. Manche across 3 procedure codes in 2024, for 58 Medicare patients. Medicare paid $4,542 for them. Every service was in an office.

CMS counts 58 Medicare patients who saw Dr. Manche in 2024. The largest group is 75 to 84, with 24 patients. 71% of them have high cholesterol, and 48% have high blood pressure. 21% are also on Medicaid. Their average risk score is 0.76, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Manche's median patient age at 30, with 38% women.

In 2024, Dr. Manche wrote 31 Medicare Part D claims for 11 patients. 48% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $724 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Manche for performance year 2024, reported as part of a group. Dr. Manche accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 86 papers to Dr. Manche, published from 2010 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Visual Acuity, Keratomileusis, Laser In Situ and Myopia. Dr. Manche has published most often in J Cataract Refract Surg. Dr. Manche's most frequent co-authors are Weldon W. Haw, MD, Anthony Liu, MD and Jennifer S. Kung.

Dmand AI links Dr. Manche to 15 clinical trials, 3 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Myopia, Astigmatism and Refractive Errors. Stanford University sponsors the most, 10.

CMS Open Payments shows 44 general payments to Dr. Manche from 5 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 84% of the total. Glaukos Corporation paid the most, $13,272.

Dmand AI lists 3 awards for Dr. Manche, most recently America's Top Doctors in 2014.

Dr. Manche graduated from Albert Einstein College of Medicine in 1990. Dr. Manche is a member of AAO.

Dr. Manche is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.